MetaADEDB 2.0 @ LMMD
Cephradine
(RDLPVSKMFDYCOR-UEKVPHQBSA-N)
Structure
SMILES
O=C([C@@H](C1=CCC=CC1)N)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)C
Type(s)
Approved
ATC code(s)
J01DB09
Molecular Formula:
C16H19N3O4S
Molecular Weight:
349.405
Log P:
1.3777
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
3
TPSA:
138.03
CAS Number(s):
38821-53-3
Synonym(s)
1.
Cephradine
2.
Anspor
3.
Cefradine
4.
Cephradine Dihydrate
5.
Cephradine, Non-Stoichiometric Hydrate
6.
Dexef
7.
Kelsef
8.
Maxisporin
9.
Nicef
10.
SQ-11436
11.
Sefril
12.
Septacef
13.
Velocef
14.
Velosef
15.
Zeefra Gé
16.
Cephradine, Non Stoichiometric Hydrate
17.
Dihydrate, Cephradine
18.
Non-Stoichiometric Hydrate Cephradine
19.
SQ 11436
20.
SQ11436
External Link(s)
MeSHD002515
PubChem Compound38103
40467109
BindingDB50292236
50370585
ChEBI3547
CHEMBLCHEMBL1604
DrugBankDB01333
DrugCentral576
IUPHAR/BPS Guide to PHARMACOLOGY4830
KEGGcpd:C06897
dr:D00264
Therapeutic Target DatabaseD06KKS
ZINC3830515
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1jaundiceFAERS: 5US FAERS
2PregnancyFAERS: 2US FAERS
3Anaphylactic shockFAERS: 1US FAERS
4Anaphylactoid ReactionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
5AstheniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
6ChromaturiaFAERS: 1US FAERS
7Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
8GlomerulonephritisFAERS: 1US FAERS
9NephrolithiasisFAERS: 1US FAERS
10PalpitationsFAERS: 1US FAERS
11PemphigusFAERS: 1US FAERS
12Renal tubular disorderFAERS: 1US FAERS
13Transaminases increasedFAERS: 1US FAERS
14TremorFAERS: 1US FAERS
15Abdominal PainCanada Vigilance: 1Canada Vigilance
16ErythemaCanada Vigilance: 1Canada Vigilance
17FlushingCanada Vigilance: 1Canada Vigilance
18Gram-Positive Bacterial Infections1638195CTD
19HeadacheCanada Vigilance: 1Canada Vigilance
20Klebsiella Infections6912860CTD
21MalaiseCanada Vigilance: 1Canada Vigilance
22Nephritis, Interstitial89922CTD
23PetechiaeCanada Vigilance: 1Canada Vigilance
24PruritusCanada Vigilance: 3Canada Vigilance
25Rash erythematousCanada Vigilance: 1Canada Vigilance
26UrticariaCanada Vigilance: 1Canada Vigilance
27VomitingCanada Vigilance: 2Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.